• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剪切波弹性成像及分子亚型对早期乳腺癌患者术后疗效的预测价值

Predictive value of shear wave elastography and molecular subtypes for postoperative efficacy in patients with early breast cancer.

作者信息

Zhao Qiao-Ying, Zhao Bing, Wu Gang

机构信息

Department of Ultrasound, Henan Provincial People's Hospital, Zhengzhou, Henan, China.

Department of Ultrasound, Zhengzhou University People's Hospital, Zhengzhou, China.

出版信息

Ann Med. 2025 Dec;57(1):2544879. doi: 10.1080/07853890.2025.2544879. Epub 2025 Aug 18.

DOI:10.1080/07853890.2025.2544879
PMID:40824193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12364092/
Abstract

OBJECTIVE

To investigate the predictive value of shear wave elastography and molecular subtypes for the postoperative efficacy of neoadjuvant chemotherapy (NAC) in patients with breast cancer (BC).

METHODS

A total of 57 patients with BC undergoing NAC were retrospectively recruited. The general and follow-up data of these patients were collected. The patients were divided into two groups: the pathological complete remission (pCR) group and the non-pCR group.

RESULTS

There were significant differences in the proportion of the elastic modulus value ( = 0.005), Ki-67 expression level ( = 0.039) and molecular subtypes ( < 0.001) between the two groups. Patients with a high elastic modulus value, a high Ki-67 level, as well as triple-negative and human epidermal growth factor receptor 2-positive BC were associated with poor overall survival and disease-free survival time ( < 0.05). Logistic regression analysis identified the elastic modulus value (odds ratio [OR]: 5.841 [3.714-6.112],  < 0.05), Ki-67 level (OR: 3.522 [1.865-3.897],  < 0.05) and molecular subtypes (OR: 4.331 [2.552-6.714],  < 0.05) as risk factors; logistic regression analysis also performed favourably for the prediction of pCR (area under the curve: 0.922 [0.871-0.934]) in patients with BC.

CONCLUSION

Elastic modulus value, Ki-67 level and molecular subtypes are risk factors for pCR in patients with BC.

摘要

目的

探讨剪切波弹性成像及分子亚型对乳腺癌患者新辅助化疗(NAC)术后疗效的预测价值。

方法

回顾性纳入57例行NAC的乳腺癌患者。收集这些患者的一般资料及随访数据。将患者分为两组:病理完全缓解(pCR)组和非pCR组。

结果

两组间弹性模量值比例(P = 0.005)、Ki-67表达水平(P = 0.039)及分子亚型(P < 0.001)存在显著差异。弹性模量值高、Ki-67水平高以及三阴性和人表皮生长因子受体2阳性乳腺癌患者的总生存期和无病生存期较差(P < 0.05)。Logistic回归分析确定弹性模量值(比值比[OR]:5.841[3.714 - 6.112],P < 0.05)、Ki-67水平(OR:3.522[1.865 - 3.897],P < 0.05)和分子亚型(OR:4.331[2.552 - 6.714],P < 0.05)为危险因素;Logistic回归分析对乳腺癌患者pCR的预测也表现良好(曲线下面积:0.922[0.871 - 0.934])。

结论

弹性模量值、Ki-67水平和分子亚型是乳腺癌患者pCR的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/f44a89d211f3/IANN_A_2544879_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/048c89e70b17/IANN_A_2544879_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/bb96952b5b59/IANN_A_2544879_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/f44a89d211f3/IANN_A_2544879_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/048c89e70b17/IANN_A_2544879_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/bb96952b5b59/IANN_A_2544879_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/12364092/f44a89d211f3/IANN_A_2544879_F0003_C.jpg

相似文献

1
Predictive value of shear wave elastography and molecular subtypes for postoperative efficacy in patients with early breast cancer.剪切波弹性成像及分子亚型对早期乳腺癌患者术后疗效的预测价值
Ann Med. 2025 Dec;57(1):2544879. doi: 10.1080/07853890.2025.2544879. Epub 2025 Aug 18.
2
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.免疫组织化学检测切除修复交叉互补基因1(ERCC1)对三阴性乳腺癌新辅助化疗反应的预测价值
Breast J. 2025 Feb 18;2025:8410670. doi: 10.1155/tbj/8410670. eCollection 2025.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer.保和平胃散加新辅助化疗治疗胃癌。
World J Gastrointest Surg. 2025 Jul 27;17(7):106487. doi: 10.4240/wjgs.v17.i7.106487.
5
The value of serial [⁶⁸Ga]Ga-FAPI-04 PET/CT in predicting pathological response and evaluating therapeutic efficacy to neoadjuvant chemotherapy in breast cancer.连续[⁶⁸Ga]Ga-FAPI-04 PET/CT在预测乳腺癌新辅助化疗的病理反应及评估治疗疗效中的价值
Eur J Nucl Med Mol Imaging. 2025 Jul 12. doi: 10.1007/s00259-025-07444-3.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Association between real-time shear wave elastography findings and HER-2 expression in breast cancer.乳腺癌实时剪切波弹性成像结果与HER-2表达之间的关联
Transl Cancer Res. 2025 Jul 30;14(7):4071-4079. doi: 10.21037/tcr-2024-2359. Epub 2025 Jul 25.
8
An XGBoost Machine Learning Based Model for Predicting Ki-67 Value ≥ 15% in TNM Stage Primary Breast Cancer Receiving Neoadjuvant Chemotherapy Using Clinical Data and Delta-Radiomic Features on Ultrasound Images and Overall Survival Analysis: A 5-Year Postoperative Follow-Up Study.基于 XGBoost 机器学习的模型,利用临床数据和超声图像的 Delta 放射组学特征预测接受新辅助化疗的 TNM 分期原发性乳腺癌中 Ki-67 值≥15%的模型:一项 5 年术后随访研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241265989. doi: 10.1177/15330338241265989.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.

本文引用的文献

1
Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review.乳腺癌潜在的诊断和预后生物标志物:综合述评。
Pathol Res Pract. 2023 Nov;251:154893. doi: 10.1016/j.prp.2023.154893. Epub 2023 Oct 20.
2
Molecular Classification of Breast Cancer.乳腺癌的分子分类。
PET Clin. 2023 Oct;18(4):441-458. doi: 10.1016/j.cpet.2023.04.002. Epub 2023 May 31.
3
Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.
建立和验证一种放射组学模型,用于预测乳腺癌患者新辅助化疗的病理完全缓解。
BMC Cancer. 2023 May 12;23(1):431. doi: 10.1186/s12885-023-10817-2.
4
Molecular Classification of Breast Cancer: Relevance and Challenges.乳腺癌的分子分类:意义与挑战。
Arch Pathol Lab Med. 2023 Jan 1;147(1):46-51. doi: 10.5858/arpa.2022-0070-RA.
5
Hybrid high-definition microvessel imaging/shear wave elastography improves breast lesion characterization.混合高清微血管成像/剪切波弹性成像可改善乳腺病变的特征化。
Breast Cancer Res. 2022 Mar 5;24(1):16. doi: 10.1186/s13058-022-01511-5.
6
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.乳腺癌中 Ki67 的评估:国际乳腺癌 Ki67 工作组的最新建议。
J Natl Cancer Inst. 2021 Jul 1;113(7):808-819. doi: 10.1093/jnci/djaa201.
7
Stiffness and Anisotropy Effect on Shear Wave Elastography: A Phantom and in Vivo Renal Study.僵硬度和各向异性对剪切波弹性成像的影响:一项肾 phantom 研究和在体研究。
Ultrasound Med Biol. 2020 Jan;46(1):34-45. doi: 10.1016/j.ultrasmedbio.2019.08.011. Epub 2019 Oct 5.
8
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians.美国医师学院关于一般风险女性乳腺癌筛查的指南声明。
Ann Intern Med. 2019 Apr 16;170(8):547-560. doi: 10.7326/M18-2147. Epub 2019 Apr 9.
9
Ki-67 protein as a tumour proliferation marker.Ki-67 蛋白作为一种肿瘤增殖标志物。
Clin Chim Acta. 2019 Apr;491:39-45. doi: 10.1016/j.cca.2019.01.011. Epub 2019 Jan 14.
10
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.《乳腺癌临床实践指南(NCCN 指南)》第 4 版 2017 年版
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.